Neurofilament relates to white matter microstructure in older adults
- PMID: 30036759
- PMCID: PMC6119102
- DOI: 10.1016/j.neurobiolaging.2018.06.023
Neurofilament relates to white matter microstructure in older adults
Abstract
Cerebrospinal fluid (CSF) neurofilament light (NFL) is a protein biomarker of axonal injury. To study whether NFL is associated with diffusion tensor imaging (DTI) measurements of white matter (WM) microstructure, Vanderbilt Memory & Aging Project participants with normal cognition (n = 77), early mild cognitive impairment (n = 15), and MCI (n = 55) underwent lumbar puncture to obtain CSF and 3T brain MRI. Voxel-wise analyses cross-sectionally related NFL to DTI metrics, adjusting for demographic and vascular risk factors. Increased NFL correlated with multiple DTI metrics (p-values < 0.05). An NFL × diagnosis interaction (excluding early mild cognitive impairment) on WM microstructure (p-values < 0.05) was detected, with associations strongest among MCI. Multiple NFL × CSF biomarker interactions were detected. Associations between NFL and worse WM metrics were strongest among amyloid-β42-negative, tau-positive, and suspected nonamyloid pathology participants. Findings suggest increased NFL, a biomarker of axonal injury, is correlated with compromised WM microstructure. Results highlight the role of elevated NFL in predicting WM damage in cognitively impaired older adults who are amyloid-negative, tau-positive, or meet suspected nonamyloid pathology criteria.
Keywords: Alzheimer's disease; Cerebrospinal fluid; Diffusion tensor imaging; Neurofilament light.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
None
Figures
References
-
- Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW, Alzheimer’s Disease Neuroimaging, I. Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative: progress and plans. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2010;6(3):239–246. - PMC - PubMed
-
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. - PMC - PubMed
-
- Baldacci F, Toschi N, Lista S, Zetterberg H, Blennow K, Kilimann I, Teipel S, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Bonuccelli U, Hampel H. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease. Alzheimers Dement 2017 - PubMed
-
- Bendlin BB, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Willette AA, Okonkwo OC, Sodhi A, Ries ML, Birdsill AC, Alexander AL, Rowley HA, Puglielli L, Asthana S, Sager MA. CSF T-Tau/Aβ(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease. PLoS One. 2012;7(6):e37720. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR000445/TR/NCATS NIH HHS/United States
- R01 AG056534/AG/NIA NIH HHS/United States
- K23 AG048347/AG/NIA NIH HHS/United States
- F32 AG058395/AG/NIA NIH HHS/United States
- U54 HD083211/HD/NICHD NIH HHS/United States
- T32 GM007347/GM/NIGMS NIH HHS/United States
- K23 AG030962/AG/NIA NIH HHS/United States
- K23 AG045966/AG/NIA NIH HHS/United States
- S10 OD023680/OD/NIH HHS/United States
- K01 AG049164/AG/NIA NIH HHS/United States
- UL1 TR002243/TR/NCATS NIH HHS/United States
- K24 AG046373/AG/NIA NIH HHS/United States
- R01 NS100980/NS/NINDS NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
